CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

ACUTAAS CHEMICALS LTD.

NSE : ACUTAASBSE : 543349ISIN CODE : INE00FF01025Industry : Pharmaceuticals & DrugsHouse : Private
BSE1936.0071.55 (+3.84 %)
PREV CLOSE () 1864.45
OPEN PRICE () 1908.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 75309
TODAY'S LOW / HIGH ()1884.50 1967.15
52 WK LOW / HIGH ()930.02 1901.35
NSE1934.1071.7 (+3.85 %)
PREV CLOSE() 1862.40
OPEN PRICE () 1910.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1934.10 (1302)
VOLUME 1236952
TODAY'S LOW / HIGH() 1885.10 1968.00
52 WK LOW / HIGH ()976.55 1902
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 2007

Management Info :

Nareshkumar Patel - Chairman Nareshkumar Patel - Managing Director

Registered Office :

Address : Plot No 440/5 & 6,Road No 82,G I D C Sachin,
Surat,
Gujarat-394230

Phone : 7227977744 / 7573015366

Website : www.acutaas.com

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
29Jan Acutaas Chemicals informs about press
Acutaas Chemicals has informed that it enclosed newspaper publication of..
19Jan Acutaas Chemicals informs about updat
Pursuant to Regulation 30 and other applicable regulations of SEBI (List..
22Dec Intimation Of Grant Of Stock Options
We herewith inform that the Nomination and Remuneration Committee has to..
11Nov Acutaas Chemicals informs about analy
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
24Oct Acutaas Chemicals informs about transc
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
Financials
in Millions
QTR Dec 25 ANNUAL 25
Net Profit1115.641595.47
Gross Profit 1507.03 2135.76
Operating Profit 1605.352434.78
Net Sales 3908.569898.35
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Gland Pharma (BSE)
 1799.40 (6.56%)
M.Cap ( in Cr)
29646.27
NGL Fine-Chem (BSE)
 1785.00 (4.58%)
M.Cap ( in Cr)
1102.78
Windlas Biotech (BSE)
 823.95 (4.76%)
M.Cap ( in Cr)
1736.66
Ipca Laboratories (BSE)
 1482.10 (2.36%)
M.Cap ( in Cr)
37601.50
Venus Remedies (BSE)
 784.65 (3.24%)
M.Cap ( in Cr)
1048.84
Shareholding Pattern
PROMOTERS 32.66%
NON-INSTITUTION 28.96%
MUTUAL FUNDS/UTI 15.11%
FI/BANKS/INSURANCE 4.15%
GOVERNMENT 0.01%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX82566.37221.69 (0.27%)
NIFTY25418.9076.15 (0.30%)
Dow Jones 49015.6012.19 (0.02%)
Nasdaq 23857.4540.35 (0.17%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI